Psychiatr. pro Praxi, 2010; 11(2): 49-50
The less common therapeutic approaches in the treatment of mania
- Psychiatrická klinika LF MU a FN Brno
The less common therapeutic approaches in the treatment of mania are usually mentioned in the international and national guidelines
as second or third line treatment. In this review only in Czech Republic available drugs are mentioned in more details. They include
undoubtedly new atypical antipsychotic and some their new formulations (paliperidone and quetiapine extended-release, long-acting
injection of risperidone) and atypical antipsychotic used for a long time without controlled trials in this indication (amisulpride, clozapine).
Further, some drugs, which are cited in the available literature but practically not used in our country are included (phenytoin,
verapamil, nifedipine, tamoxifene, allopurinol).
Keywords: antimanic drugs, paliperidone ER, quetiapine ER, risperidone long-acting injection, amisulpride, clozapine, phenytoin, tamoxifene, allopurinol
Published: March 1, 2010 Show citation
References
- Conley R, Gusta SK, Sathyan G. Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form. Curr Med Res Opin 2006; 22: 1879-1892.
Go to original source... 
Go to PubMed... - Grunze H, Vieta E, Goodwin G, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the treatment of acute mania. World J Biol Psychiatry 2009; 10: 85-116. Go to original source... Go to PubMed...
- Cutler AJ, Datto C, Nordenhem A, et al. Effectiveness of extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar mania. Int J Neuropsychopharmacol 2008; 11(Suppl. 1): 184.
- Yatham LN, Kennedy SH, Schaffer A, et al. Canadian network for Mood and Anxiety treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disorders 2009; 11: 225-255. Go to original source... Go to PubMed...
- Fountoulakis K, Vieta E. Treatment of bipolar disorder. A systematic review of available data and clinical perspectives. Int J Neuropsychopharmacology 2008; 11: 999-1029. Go to original source... Go to PubMed...
- Thomas P, Vieta E. for the SOLEMANIA study group 2008. Amisulpride plus valproate vs. haloperidol plus valproate in the treatment of acute mania of bipolar I patients. A multicenter, open label, randomized, comparative trial. Neuropsychiatr Dis Treat 2008; 4: 1-12. Go to original source... Go to PubMed...
- Češková E, Herman E, Doubek P, Praško J. Bipolární afektivní porucha. In Raboch J, Anders M, Praško J, Kellerová P. Psychiatrie. Doporučené postupy léčby v psychiatrické péči II. Praha: Infopharm 2006; 88-96.
- Mishory A, Yaroslavsky Y, Bersudsky Y, Belmaker RH. Phenytoin as antimanic anticonvulsant. A controlled study. Am J Psychiatry 2000; 157: 463-465. Go to original source... Go to PubMed...
- Meador KJ, Baker GA, Browning N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009; 360: 1597-1605. Go to original source... Go to PubMed...
- Machado-Vieira R, Soares JC, Lara DR, et al. A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. J Clin Psychiatry 2008; 69: 1237-1245. Go to original source... Go to PubMed...
- Young SN. Rapid tryptophane depletion as a treatment for acute mania: safety and mechanism of the therapeutic effect. Bipolar Disord 2009; 11: 557-558. Go to PubMed...